The Enterprise Value as of November 2024 (TTM) for Tenaya Therapeutics, Inc. (TNYA) is 156.24M

According to Tenaya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 156.24M. This represents a change of -31.25% compared to the average of 227.24M of the last 4 quarters.

Tenaya Therapeutics, Inc. (TNYA) Historical Enterprise Value (quarterly & annually)

How has TNYA Enterprise Value performed in the past?

The mean historical Enterprise Value of Tenaya Therapeutics, Inc. over the last ten years is 416.78M. The current 156.24M Enterprise Value has changed 3.65% with respect to the historical average. Over the past ten years (40 quarters), TNYA's Enterprise Value was at its highest in in the December 2021 quarter at 757.34M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Tenaya Therapeutics, Inc. (TNYA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tenaya Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tenaya Therapeutics, Inc. (TNYA) Average Enterprise Value

How has TNYA Enterprise Value performed in the past?

The current Enterprise Value of Tenaya Therapeutics, Inc. (TNYA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tenaya Therapeutics, Inc. (TNYA) Enterprise Value vs. Peers

How is TNYA’s Enterprise Value compared to its peers?

Tenaya Therapeutics, Inc.’s Enterprise Value is less than Bicycle Therapeutics plc (747.24M), less than IGM Biosciences, Inc. (913.50M), less than Monte Rosa Therapeutics, Inc. (480.81M), less than Stoke Therapeutics, Inc. (496.70M), less than Biomea Fusion, Inc. (244.86M), less than Akero Therapeutics, Inc. (1.96B), greater than Homology Medicines, Inc. (-103303255.00), less than Gossamer Bio, Inc. (312.60M), less than Rani Therapeutics Holdings, Inc. (165.61M), greater than Vincerx Pharma, Inc. (4.79M), less than Corvus Pharmaceuticals, Inc. (554.14M), greater than ALX Oncology Holdings Inc. (80.68M), greater than Eyenovia, Inc. (57.02M), less than Alpha Tau Medical Ltd. (163.31M), less than Ocular Therapeutix, Inc. (1.21B), less than Inozyme Pharma, Inc. (308.76M),

Build a custom stock screener for Tenaya Therapeutics, Inc. (TNYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenaya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenaya Therapeutics, Inc. (TNYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenaya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.